Biotech

All Articles

Daiichi pays Merck $170M to form bronchi cancer cells T-cell engager contract

.Merck &amp Co. has rapidly recouped a number of the expenses of its own Javelin Therapies purchase,...

BioMarin stops preclinical gene therapy for heart condition

.After BioMarin performed a springtime tidy of its pipe in April, the company has decided that it al...

Eisai plants molecular glue SEED along with $1.5 B biobucks work

.Significant Pharmas continue to be stuck to the concept of molecular adhesive degraders. The most u...

Life science credit report company unveils with $600M

.A brand-new international life science credit rating organization, called Symbiotic Funds, has rais...

BMS trenches TIGIT, leaving $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing yet another significant bet from the Caforio era, canceling a bargain...

Nuvation halts wager inhibitor after taking into consideration phase 1 record

.After having a look at period 1 information, Nuvation Biography has actually chosen to stop work wi...

' Professional intuition' led FDA consultants to back Zevra's uncommon illness med

.Zevra Therapies' unusual disease medicine seems to be on the pathway to confirmation this fall afte...

Pfizer takes $230M struck after axing fell short DMD genetics therapy

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) gene treatment failure has blown a $230 thousand ...

AC Immune observes 'landmark' possible in Alzheimer's drug records

.After more than two decades of work on neurodegenerative conditions, Swiss biotech AC Immune system...

GSK falls ph. 2 HPV vaccine over lack of best-in-class potential

.GSK has actually scrapped a stage 2 individual papillomavirus (HPV) vaccination coming from its own...